IRIS
GIORGINO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 36.686
AS - Asia 12.967
EU - Europa 11.835
SA - Sud America 3.630
Continente sconosciuto - Info sul continente non disponibili 1.251
AF - Africa 582
OC - Oceania 35
Totale 66.986
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 35.547
SG - Singapore 5.392
IT - Italia 4.473
CN - Cina 2.871
BR - Brasile 2.853
HK - Hong Kong 1.585
SE - Svezia 1.299
RU - Federazione Russa 1.121
DE - Germania 1.031
VN - Vietnam 852
UA - Ucraina 829
FI - Finlandia 820
FR - Francia 818
GB - Regno Unito 636
CA - Canada 493
IN - India 458
BD - Bangladesh 394
AR - Argentina 243
ID - Indonesia 222
IQ - Iraq 177
MX - Messico 148
TR - Turchia 144
NL - Olanda 134
EC - Ecuador 125
PK - Pakistan 117
CI - Costa d'Avorio 116
CO - Colombia 116
JP - Giappone 109
ZA - Sudafrica 109
PL - Polonia 101
VE - Venezuela 99
BE - Belgio 92
SA - Arabia Saudita 92
AT - Austria 83
ES - Italia 82
IE - Irlanda 81
CR - Costa Rica 77
MA - Marocco 68
MY - Malesia 66
UZ - Uzbekistan 63
PH - Filippine 59
TN - Tunisia 58
JM - Giamaica 57
CL - Cile 55
HN - Honduras 54
LT - Lituania 50
GT - Guatemala 49
NI - Nicaragua 49
SV - El Salvador 49
TT - Trinidad e Tobago 47
IL - Israele 44
EG - Egitto 43
PR - Porto Rico 41
PE - Perù 39
JO - Giordania 37
PY - Paraguay 37
AE - Emirati Arabi Uniti 35
KR - Corea 31
DZ - Algeria 30
KE - Kenya 29
NP - Nepal 28
UY - Uruguay 28
AU - Australia 27
CH - Svizzera 27
CW - ???statistics.table.value.countryCode.CW??? 27
BO - Bolivia 26
ET - Etiopia 26
CZ - Repubblica Ceca 25
LB - Libano 25
GP - Guadalupe 22
SC - Seychelles 22
AZ - Azerbaigian 20
GR - Grecia 19
KG - Kirghizistan 18
KZ - Kazakistan 17
EE - Estonia 15
OM - Oman 15
SN - Senegal 15
LY - Libia 14
PA - Panama 14
PS - Palestinian Territory 14
DO - Repubblica Dominicana 12
TH - Thailandia 12
AL - Albania 11
PT - Portogallo 11
RS - Serbia 11
SY - Repubblica araba siriana 11
BG - Bulgaria 9
HU - Ungheria 9
IR - Iran 9
BB - Barbados 8
RO - Romania 8
AM - Armenia 7
DK - Danimarca 7
EU - Europa 7
KW - Kuwait 7
NZ - Nuova Zelanda 7
QA - Qatar 7
BY - Bielorussia 6
BZ - Belize 6
Totale 65.638
Salva come PNG Salva come JPEG
Città #
Ashburn 4.659
Singapore 2.878
San Jose 2.698
Fairfield 2.564
Woodbridge 2.146
Jacksonville 1.875
Chandler 1.866
Hong Kong 1.558
Houston 1.514
Milan 1.375
Cambridge 1.055
Seattle 994
Ann Arbor 973
Nyköping 969
Council Bluffs 861
Wilmington 814
Beijing 652
New York 591
Rome 532
Lauterbourg 513
Roxbury 508
Los Angeles 503
Lawrence 499
Dearborn 483
Nanjing 467
Dallas 421
Bari 389
Helsinki 388
Boardman 378
Des Moines 312
São Paulo 306
Santa Clara 291
Ho Chi Minh City 273
Columbus 270
Brooklyn 181
Inglewood 178
Princeton 175
Buffalo 173
Hanoi 161
London 145
San Diego 142
Chicago 138
Munich 133
Nanchang 130
Falkenstein 127
Jakarta 127
Hebei 125
Abidjan 116
Phoenix 115
Shenyang 111
Figino 108
Toronto 108
Montreal 103
San Francisco 103
Rio de Janeiro 102
Orem 97
Moscow 93
Atlanta 91
Tokyo 90
Turin 90
Brussels 87
Frankfurt am Main 84
Jiaxing 84
Nuremberg 84
Baghdad 82
Paris 81
Naples 80
Tianjin 80
Warsaw 78
Belo Horizonte 77
North Bergen 76
Dublin 75
Denver 69
Guangzhou 69
Pune 68
Chennai 67
San José 64
Dong Ket 63
Hefei 62
Curitiba 59
Changsha 58
Jinan 56
Tashkent 54
Amsterdam 52
Johannesburg 50
Redwood City 49
Managua 48
Porto Alegre 45
The Dalles 45
Kunming 44
Mexico City 44
Miami 44
Quito 43
Bologna 42
Shanghai 41
Washington 41
Brasília 40
Campinas 40
Manchester 40
Boston 39
Totale 42.241
Salva come PNG Salva come JPEG
Nome #
Effects of CPAP on testosterone levels in patients with obstructive sleep apnea: a meta-analysis study 680
Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper 407
Efficacy and safety of once- weekly dulaglutide versus insulin glargine in patients with type 2 Diabetes on metformin and glimepiride (AWARD-2) 392
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial 343
Lysine 63 ubiquitination is involved in the progression of tubular damage in diabetic nephropathy 296
Reduced SIRT1 and SIRT2 expression promotes adipogenesis of human visceral adipose stem cells and associates with accumulation of visceral fat in human obesity 270
Adipose Tissue Dysfunction and Obesity-Related Male Hypogonadism 261
Long-term exposure of pancreatic β-cells to palmitate results in SREBP-1C-dependent decreases in GLP-1 receptor signaling via CREB and AKT and insulin secretory response 252
Mini Review: Effect of GLP-1 Receptor Agonists and SGLT-2 Inhibitors on the Growth Hormone/IGF Axis 244
Abnormalities of insulin-like growth factor-l Signaling and Impaired Cell Proliferation in Osteoblasts from Subjects with Osteoporosis 236
Correction of intermittent hypoxia reduces inflammation in obese subjects with obstructive sleep apnea 235
Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases 230
The Long-Term Impact of Renin-Angiotensin System (RAS) Inhibition on Cardiorenal Outcomes (LIRICO): A Randomized, Controlled Trial 230
Urinary Excretion of Kidney Aquaporins as Possible Diagnostic Biomarker of Diabetic Nephropathy 226
GLP-1: a new approach for type 2 diabetes therapy 224
PKB/Akt and MAPK/ERK phosphorylation is highly induced by inositols: Novel potential insights in endothelial dysfunction in preeclampsia 219
Urinary miRNA-27b-3p and miRNA-1228-3p correlate with the progression of Kidney Fibrosis in Diabetic Nephropathy 219
Italian consensus for the classification and reporting of thyroid cytology: the risk of malignancy between indeterminate lesions at low or high risk. A systematic review and meta-analysis 217
Efficacy and safety of very low calorie ketogenic diet (VLCKD) in patients with overweight and obesity: A systematic review and meta-analysis 214
The p66Shc Protein Controls Redox Signaling and Oxidation-Dependent DNA Damage in Human Liver Cells 211
Wound healing in diabetes: hemorheological and microcirculatory aspects. 210
Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study 209
Diabetes and cancer: pathophysiological fundamentals of a 'dangerous affair' 206
Insulin and Insulin Receptors in Adipose Tissue Development 201
Deregulation of autophagy under hyperglycemic conditions is dependent on increased lysin63 ubiquitination: a candidate mechanism in the progression of diabetic nephropathy 199
GLP-1 Receptor Agonist Added to Insulin versus Basal-plus or Basal-bolus Insulin Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis 198
Irisin Increases the Expression of Anorexigenic and Neurotrophic Genes in Mouse Brain 191
Increased carotid IMT in overweight and obese women affected by Hashimoto's thyroiditis: an adiposity and autoimmune linkage? 191
Diabetic foot: clinical approach 188
GLP-1 Receptor Activation Inhibits Palmitate-Induced Apoptosis via Ceramide in Human Cardiac Progenitor Cells 188
Clinical view on the need to develop new anti-diabetic drugs 187
The p66Shc redox adaptor protein is induced by saturated fatty acids and mediates lipotoxicity-induced apoptosis in pancreatic beta cells 187
Achievement of glycaemic control is associated with improvements in lipid profile with iGlarLixi versus iGlar: A post hoc analysis of the LixiLan-L trial 187
Adipose tissue precursor cells 185
Heterogeneity and Similarities in GLP-1 Receptor Agonist Cardiovascular Outcomes Trials 185
IGF-I and IGF-I receptor: implications in the pathophysiology of thyroid cancer 184
Adipose tissue, metabolic syndrome and polycystic ovary syndrome: from pathophysiology to treatment 183
Interventional therapy in diabetic foot: Risk factors, clinical events and prognosis at one year follow-up (a study of 103 cases) 182
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 182
Effects of irisin on leptin and ghrelin secretion and expression of the major appetite regulators in mouse brain 179
Association between Follicular Fluid Leptin and Serum Insulin Levels in Nonoverweight Women with Polycystic Ovary Syndrome 178
Atrial natriuretic factor (ANF) in obesity: metabolic clearance rate, platelet clearance receptor number and effectiveness. 177
Adherence to antihyperglycemic medications and glucagon-like peptide 1-receptor agonists in type 2 diabetes: Clinical consequences and strategies for improvement 177
Irisin improves the secretory defects of pancreatic islets from type 2 diabetic subjects 177
Analysis of insulin sensitivity in adipose tissue of patients with primary aldosteronism 176
The myokine irisin is released in response to saturated fatty acids and promotes pancreatic β-cell survival and insulin secretion 176
Exendin-4 protects pancreatic beta cells from palmitate-induced apoptosis by interfering with GPR40 and the MKK4/7 stress kinase signalling pathway. 176
Relationship between risk factors and mortality in type 1 diabetic patients in europe: The eurodiab prospective complications study (PCS) 176
Association between differentiated thyroid carcinoma and chronic lymphocytic thyroiditis: a post-hoc evaluation in patients undergoing total thyroidectomy 176
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 175
Irisin Enhances Pancreatic Beta-Cell Survival and Insulin Secretion and Can Mediate the Metabolic Cross Talk between the Skeletal Muscle and Endocrine Pancreas 175
Comparison of Distinct GLP-1 Receptor Agonists in Palmitate-induced Incretin Resistance of Pancreatic Beta Cells 175
Rare diseases in clinical endocrinology: A taxonomic classification system 174
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 174
Efficacy and Safety of Different Hybrid Closed Loop Systems for Automated Insulin Delivery in People With Type 1 Diabetes: A Systematic Review and Network Meta-Analysis 173
Association between physical activity estimated by the International physical activity questionnaire and UKPDS cardiovascular risk in score type 2 diabetes. 173
Effects of Extra Virgin Olive Oil Polyphenols on Pancreatic Beta-Cell Function and Survival 172
Abnormalities of cardiac insulin signaling in experimental diabetes 171
The p66Shc protein mediates saturated fatty acid-induced insulin resistance in pancreatic beta cells 171
Cardiovascular and Renal Effectiveness of GLP-1 Receptor Agonists vs. Other Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Real-World Studies 171
Apoptotic and survival signals triggered by high glucose in human mesangial cells. 170
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy 170
Adipose Tissue Inflammation and Pulmonary Dysfunction in Obesity 169
NANOG plays a hierarchical role in the transcription network regulating the pluripotency and plasticity of adipose tissue-derived stem cells 168
The SUMO-conjugating enzyme Ubc9 is essential for insulin-responsive glucose transport in adipocytes. 167
A family history of Type 2 diabetes is associated with increased plasma levels of C-reactive protein in non-smoking healthy adult women 167
Characterization of the gut microbiota and metabolome in healthy and unhealthy obese patients 166
Dehydroepiandrosterone stimulates glucose uptake in human and murine adipocytes by inducing GLUT1 and GLUT4 translocation to the plasma membrane 165
Ubc9 regulation of glucose transport in 3T3-L1 adipocytes is differentiation-dependent. 164
A master course on "Methodologies for bio-medical research in diabetes". 164
Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: A comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program 164
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE) 164
Effect of once-weekly dulaglutide versus insulin glargine in people with type 2 diabetes and different baseline glycaemic patterns: A post hoc analysis of the AWARD-2 clinical trial 164
Chronic palmitate excess results in reduced exendin-4 action and signalling via CREB and Akt in pancreatic beta cells 164
RAS/BRAF mutational status in familial non‑medullary thyroid carcinomas: A retrospective study 162
Association of Hashimoto’s thyroiditis and nodular pathology: is there an increased risk for thyroid papillary carcinoma? 161
Effects of extra virgin olive oil polyphenols on beta-cell function and survival 161
CLU TRANSCRIPT VARIANTS AS POTENTIAL BIOMARKERS FOR THE THYROID CANCER 160
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial. 160
Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes: The PRISMA Randomized Trial. 159
Dysmetabolic adipose tissue in obesity: morphological and functional characteristics of adipose stem cells and mature adipocytes in healthy and unhealthy obese subjects 159
Efficacy and safety of flash glucose monitoring in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis 159
The Burden of Structured Self-Monitoring of Blood Glucose on Diabetes-Specific Quality of Life and Locus of Control in Patients with Noninsulin-Treated Type 2 Diabetes: The PRISMA Study 158
The Sentiment Analysis of Tweets as a New Tool to Measure Public Perception of Male Erectile and Ejaculatory Dysfunctions 155
Commentary: Glucose control: Not just a bystander in GLP-1RA-mediated cardiovascular protection 155
Cardiovascular disease and glycemic control in type 2 diabetes: now that the dust is settling from large clinical trials. 154
Functional loss of pancreatic islets in type 2 diabetes: How can we halt it? 154
Carriers of the TCF7L2 rs7903146 variant with GMD have an increate risk of developing impaired glucose regulation after pregnancy. 153
A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus 153
Adipose Tissue Function and Dysfunction: Organ Cross-Talk and Metabolic Risk 152
Decreased IRS phosphorylation and altered Erk activation in osteoblasts from osteoporotic subjects. 152
The METABOLIC Study: multidimensional assessment of health and functional status in older patients with type 2 diabetes taking oral antidiabetic treatment. 152
Effect of family history of type 2 diabetes on white blood cell count in adult women 152
Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: A cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study 152
Biological specificity of visceral adipose tissue and therapeutic intervention 151
Abnormalities in IGF-I signalling and impaired cell proliferation in osteoblasts from patients with osteoporosis. 150
Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study 149
Glucagon-Like Peptide-1 Counteracts Oxidative Stress-Dependent Apoptosis of Human Cardiac Progenitor Cells by Inhibiting the Activation of the c-Jun N-terminal Protein Kinase Signaling Pathway 147
Efficacy of Vandetanib in treating locally advanced or metastatic medullary thyroid carcinoma according to RECIST Criteria: A systematic review and meta-analysis 147
The myokine irisin is released in response to saturated fatty acids and enhances pancreatic beta cell survival and insulin secretion 147
Totale 19.261
Salva come PNG Salva come JPEG
Categoria #
all - tutte 268.495
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 268.495
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.543 0 0 0 0 127 179 106 200 252 222 581 876
2022/20235.254 761 491 261 471 651 762 78 575 978 40 101 85
2023/20241.834 158 380 107 128 179 413 39 157 23 50 13 187
2024/20258.840 128 124 710 295 233 907 667 825 445 481 1.334 2.691
2025/202621.006 2.727 841 1.169 2.139 2.105 1.194 2.477 652 2.009 2.310 825 2.558
2026/20279.297 1.295 1.438 2.341 4.152 71 0 0 0 0 0 0 0
Totale 66.986